Dr. Antonio Giordano, MD,PhD
Claim this profileDana-Farber Cancer Institute
Area of expertise
Breast Cancer
Antonio Giordano, MD,PhD has run 6 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Antonio Giordano, MD,PhD has run 2 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
Dana Farber Cancer Institute
Clinical Trials Antonio Giordano, MD,PhD is currently running
MEN2312
for Breast Cancer
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.
Recruiting
1 award
Phase 1
2 criteria
XMT-1660
for Breast Cancer
This trial tests a new drug called XMT-1660 to see if it is safe and what side effects it might have. It focuses on patients whose cancer has come back, spread locally, or spread throughout the body. The study will first find a safe dose and then check if this dose helps treat solid tumors.
Recruiting
1 award
Phase 1
More about Antonio Giordano, MD,PhD
Clinical Trial Related
3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Antonio Giordano, MD,PhD has experience with
- Onvansertib
- Paclitaxel
- ORM-5029
- Pembrolizumab
- BDC-3042
- MEN2312
Breakdown of trials Antonio Giordano, MD,PhD has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Antonio Giordano, MD,PhD specialize in?
Antonio Giordano, MD,PhD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are PR negative.
Is Antonio Giordano, MD,PhD currently recruiting for clinical trials?
Yes, Antonio Giordano, MD,PhD is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Antonio Giordano, MD,PhD has studied deeply?
Yes, Antonio Giordano, MD,PhD has studied treatments such as Onvansertib, Paclitaxel, ORM-5029.
What is the best way to schedule an appointment with Antonio Giordano, MD,PhD?
Apply for one of the trials that Antonio Giordano, MD,PhD is conducting.
What is the office address of Antonio Giordano, MD,PhD?
The office of Antonio Giordano, MD,PhD is located at: Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana-Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.